Outcomes of Relapsed or Refractory Acute Myeloid Leukemia Patients Failing Venetoclax‐based Salvage Therapies

Andrius Zucenka,Regina Pileckyte,Igoris Trociukas,Valdas Peceliunas,Vilmante Vaitekenaite,Kazimieras Maneikis,Linas Davainis,Tadas Zvirblis,Mindaugas Stoskus,Egle Gineikiene,Rimvydas Norvilas,Vaidas Dirse, Agne Surauciute,Emile Zucenkiene,Laimonas Griskevicius

European Journal of Haematology（2020）

引用 7|浏览29

暂无评分

摘要

We conducted a retrospective analysis to evaluate the outcomes of 28 heavily pretreated (median 3 (2‐6) treatment lines, sixteen (57%) allotransplanted) relapsed/refractory acute myeloid leukemia patients who had failed salvage venetoclax‐based therapies.

查看译文

关键词

acute myeloid leukemia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要